- Ezetimibe is a drug that lowers plasma cholesterol levels recommended as second line therapy for those intolerant of statins or unable to achieve target low-density lipoprotein (LDL) cholesterol levels on statins alone.
Ezetimibe in combination with a statin has also been shown to have cardiovascular benefits in patients with diabetes.
- SMB’s product offers better compliance due to the use of our Divule® technology which allows easier swallowing and a flexible dosing regimen ranging from 5mg to 15mg per intake if required.
- Our Ezetimibe product is proposed in capsule shaped divisible tablet containing 10 mg of ezetimibe.
